Danaher Reports First Quarter 2021 Results.
Q1 ADJUSTED NON-GAAP EARNINGS PER SHARE $2.52.
Q1 EARNINGS PER SHARE $2.29.
Q1 REVENUE ROSE 58 PERCENT TO $6.9 BILLION.
FOR Q2 2021, COMPANY ANTICIPATES THAT NON-GAAP CORE REVENUE GROWTH WILL BE IN MID-20 PERCENT RANGE.
FOR FULL YEAR 2021, COMPANY NOW ANTICIPATES THAT NON-GAAP CORE REVENUE GROWTH RATE INCLUDING CYTIVA WILL BE IN HIGH-TEENS PERCENT RANGE.
